Pierluigi Bonifazi
Overview
Explore the profile of Pierluigi Bonifazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zelante T, Montagnoli C, Bozza S, Bellocchio S, Bonifazi P, De Luca A, et al.
Med Mycol
. 2018 Nov;
44(Supplement_1):S237-S243.
PMID: 30408910
Efficient response to Aspergillusfumigatus requires different mechanisms. Polymorphonuclear neutrophils (PMNs) are the predominant immune cells in the acute stage of most fungal infections and play a crucial role in determining...
2.
Sorci G, Giovannini G, Riuzzi F, Bonifazi P, Zelante T, Zagarella S, et al.
PLoS Pathog
. 2011 Mar;
7(3):e1001315.
PMID: 21423669
Humans inhale hundreds of Aspergillus conidia without adverse consequences. Powerful protective mechanisms may ensure prompt control of the pathogen and inflammation. Here we reveal a previously unknown mechanism by which...
3.
Perruccio K, Bonifazi P, Topini F, Tosti A, Bozza S, Aloisi T, et al.
Ann N Y Acad Sci
. 2010 Jun;
1194:153-61.
PMID: 20536464
We designed a phase I/II clinical study to determine safety and efficacy of thymosin alpha1 (Talpha1) administration in recipients of one HLA haplotype (haploidentical) stem cell transplants for hematologic malignancies....
4.
DAngelo C, De Luca A, Zelante T, Bonifazi P, Moretti S, Giovannini G, et al.
J Immunol
. 2009 Sep;
183(7):4609-18.
PMID: 19734205
Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by life-threatening bacterial and fungal infections and hyperinflammation. The susceptibility to aspergillosis in experimental CGD (p47(phox-/-) mice) is associated with the...
5.
Bozza S, Clavaud C, Giovannini G, Fontaine T, Beauvais A, Sarfati J, et al.
J Immunol
. 2009 Jul;
183(4):2407-14.
PMID: 19625642
The ability of the fungus Aspergillus fumigatus to activate, suppress, or subvert host immune response during life cycle in vivo through dynamic changing of cell wall structure and secretion implicates...
6.
Zelante T, Bozza S, De Luca A, DAngelo C, Bonifazi P, Moretti S, et al.
Med Mycol
. 2008 Jul;
47 Suppl 1:S162-9.
PMID: 18608926
Innate and adaptive immune responses act to generate the most effective form of immunity for protection against Aspergillus fumigatus. The decision of how to respond is still primarily determined by...
7.
Romani L, Zelante T, De Luca A, Bozza S, Bonifazi P, Moretti S, et al.
Med Mycol
. 2008 Jul;
47 Suppl 1:S154-61.
PMID: 18608907
Innate responses combine with adaptive immunity to generate the most effective form of resistance against Aspergillus fumigatus. A complex set of signaling networks initiate both innate and adaptive immunity in...
8.
Bozza S, Zelante T, Moretti S, Bonifazi P, DeLuca A, DAngelo C, et al.
J Immunol
. 2008 Mar;
180(6):4022-31.
PMID: 18322211
TLRs contribute to the inflammatory response in fungal infections. Although inflammation is an essential component of the protective response to fungi, its dysregulation may significantly worsen fungal diseases. In this...
9.
De Luca A, Montagnoli C, Zelante T, Bonifazi P, Bozza S, Moretti S, et al.
J Immunol
. 2007 Oct;
179(9):5999-6008.
PMID: 17947673
The ability of regulatory T (Treg) cells to inhibit aspects of innate and adaptive immunity is central to their protective function in fungal infections. In murine candidiasis, CD4(+)CD25(+) Treg cells...
10.
Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, et al.
Eur J Immunol
. 2007 Sep;
37(10):2695-706.
PMID: 17899546
Although inflammation is an essential component of the protective response to fungi, its dysregulation may significantly worsen fungal diseases. We found here that the IL-23/IL-17 developmental pathway acted as a...